Thomas Sparks is senior partner at Pillsbury Winthrop Shaw Pittman LLP. His practice includes public and private offerings of equity and debt securities, venture capital, intellectual property matters, joint ventures, corporate collaborations, mergers and acquisitions and tender offers. His clients have included companies such as Athena Neurosciences, Inc, Althea Technologies, Inc., Applied Molecular Evolution, Inc., Biosite Incorporated, Cardima, Inc., Elan Corporation, plc, Gen-Probe Incorporated, Hybritech Incorporated, IDEC Pharmaceuticals Incorporated, The Immune Response Corporation, RAVEN Biotechnologies, Inc., Incyte, Nanogen, Inc., Oncomed Pharmaceuticals, Inc., Pharmacia Corporation, Pyxis Corporation, RelayHealth Corporation, St. Francis Medical Technologies, Inc., Selective Genetics, Inc., SICOR Inc., Viagene, Inc. and Vical Incorporated.
Mr. Sparks served as a member of the Clinton Administration Transition Team at the Department of Health and Human Services.
Mr. Sparks has provided leadership in the firm's representation of life science and technology companies for more than 30 years.